Mode
Text Size
Log in / Sign up

Octenidine gel plus hydrogel dressing improved healing progress versus silver-containing calcium alginate dressing in patients with chronic venous leg ulcers over 4 weeks.

Octenidine gel plus hydrogel dressing improved healing progress versus silver-containing calcium alg…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider octenidine gel plus hydrogel dressing for chronic venous leg ulcers, though safety data were not reported.

This randomized controlled trial evaluated wound healing in 60 patients with chronic venous leg ulcers. Participants were assigned to receive either octenidine gel plus hydrogel dressing or a silver-containing calcium alginate dressing. The study followed patients for 4 weeks to assess outcomes.

The primary outcome measured wound healing progress using the RESVECH 2.0 Scoring Scale. Secondary outcomes included wound size, wound edges, tissue in the wound bed, exudate, and signs of infection or inflammation. The experimental group demonstrated statistically significant improvements in the RESVECH 2.0 total score and parameters. In contrast, the control group experienced no significant changes in these metrics.

Safety and tolerability data were not reported. Adverse events, serious adverse events, discontinuations, and overall tolerability were not reported. The study did not specify p-values or confidence intervals for the reported statistical significance.

The authors suggest that incorporating hydrogel-based antiseptic dressings into standard treatment protocols may improve patient outcomes and reduce healing time. However, the absence of reported safety data and specific statistical values limits the precision of the clinical interpretation.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
IntroductionVenous leg ulcers (VLUs) represent a major chronic wound condition associated with high recurrence rates, prolonged healing, and substantial socioeconomic burden. Hydrogels have recently gained attention as effective wound dressings due to their moisture-retentive and biocompatible properties. This study aimed to evaluate the clinical effectiveness of a combined therapy using octenidine gel and a hydrogel dressing compared to a silver-containing calcium alginate dressing in patients with VLUs.MethodsA randomized controlled trial was conducted, enrolling 60 patients with chronic VLUs. Participants were randomly assigned to either an experimental group (octenidine gel + hydrogel dressing) or a control group (silver-containing calcium alginate dressing). Wound healing progress was assessed using the RESVECH 2.0 Scoring Scale, which evaluates six wound parameters of effective wound healing. Measurements were taken at baseline and after 4 weeks of treatment.ResultsAfter 4 weeks, the experimental group showed statistically significant improvements in wound size, wound edges, tissue in the wound bed, exudate, infection/inflammation signs, and overall RESVECH 2.0 total score. No significant changes were observed in the control group. Between-group comparisons confirmed superior healing outcomes in the experimental group.DiscussionThe combination of octenidine gel and a hydrogel dressing significantly enhanced healing outcomes in patients with VLUs compared to conventional silver-containing dressings, suggesting that hydrogel-based antiseptic therapy is an effective alternative for VLU management. Given the chronic nature and high recurrence rates of VLUs, incorporating hydrogel-based antiseptic dressings into standard treatment protocols may improve patient outcomes and reduce healing time.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.